[QODLink]
The Cure

Unsung Hero: Louise Pearce

How the physician risked her life to test a new drug she believed would cure sleeping sickness.

Last updated: 21 Jan 2014 11:21
Email Article
Print Article
Share article
Send Feedback

Louise Pearce risked her life to test a new drug she believed would cure sleeping sickness.

In 1920, a sleeping sickness epidemic broke out across some African countries, with the Congo - at that time a Belgian colony - one of the worst hit.

Dr Louise Pearce volunteered to travel alone to the colony to test out a drug she believed could help cure victims. For decades, the drug, Tryparsamide remained the standard treatment for sleeping sickness.

Following her success, Louise Pearce returned to the US and continued her research into susceptibility and resistance to infection with Dr Wade Hampton Brown. She retired in 1951 and died eight years later following a short illness.

 

 

Click here for more on The Cure 

 

170

Source:
Al Jazeera
Email Article
Print Article
Share article
Send Feedback
Topics in this article
People
Country
Featured on Al Jazeera
More than one-quarter of Gaza's population has been displaced, causing a humanitarian crisis.
Ministers and MPs caught on camera sleeping through important speeches have sparked criticism that they are not working.
Muslim charities claim discrimination after major UK banks began closing their accounts.
Italy struggles to deal with growing flood of migrants willing to risk their lives to reach the nearest European shores.
Featured
Russia is expected to be the main topic of the two-day NATO summit this week in Wales.
In Brussels, NGO staff are being trained to fill the shortfall of field workers in West Africa.
Lawsuit by 6-year-old girl, locked up for a year, reignites debate over indefinite detention of 'boat people'.
Indonesian and Malaysian authorities are keeping a close eye on local supporters of the hard-line Middle East group.
Citizens of the tiny African nation say they're increasingly anxious of the fallout after alleged coup.
join our mailing list